---
title: "Shanghai Bio-Heart Approves Strategic Resolutions During Recent Meetings"
date: "2025-02-13 22:09:23"
summary: "Maximize Your Portfolio with Data Driven Insights:Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions. Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart PortfolioShanghai Bio-Heart Biological Technology Co., Ltd...."
categories:
  - "tipranks_announcements"
lang:
  - "en"
translations:
  - "en"
tags:
  - "tipranks_announcements"
menu: ""
thumbnail: "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1561815367-1-750x406.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

### Maximize Your Portfolio with Data Driven Insights:

* Leverage the power of [TipRanks' Smart Score](https://www.tipranks.com/screener/top-smart-score-stocks), a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
* Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with  [Your Smart Portfolio](https://www.tipranks.com/smart-portfolio/holdings)

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H ( [(HK:2185)](https://www.tipranks.com/stocks/hk:2185) ) has provided an announcement.

Shanghai Bio-Heart Biological Technology Co., Ltd. successfully conducted its Extraordinary General Meeting and Class Meetings, passing all proposed resolutions. This includes a major transaction involving the deemed disposal of equity interest in a subsidiary and amendments to the company’s articles of association, reflecting strategic shifts and governance updates that may influence its operational and market strategy.

**More about Shanghai Bio-Heart Biological Technology Co., Ltd. Class H**

Shanghai Bio-Heart Biological Technology Co., Ltd. operates in the biotechnology sector, focusing on the development and commercialization of medical technologies and solutions. The company is primarily engaged in producing cardiovascular devices, aiming to enhance heart health and treatment outcomes.

**YTD Price Performance:** 5.49%

**Average Trading Volume:** 47,626

**Technical Sentiment Consensus Rating:** Buy

**Current Market Cap:** HK$724.1M

For an in-depth examination of 2185 stock, go to [TipRanks’ Stock Analysis page](https://www.tipranks.com/stocks/hk:2185/stock-analysis).

Trending Articles:
------------------

* [Jensen Huang’s Net Worth: The Billionaire Who Leads the World’s Largest Chip Company Nvidia](https://www.tipranks.com/news/jensen-huangs-net-worth-the-billionaire-who-leads-the-worlds-largest-chip-company-nvidia)
* [Super Micro (SMCI) Wins a New Street-High Price Target from Northland Securities](https://www.tipranks.com/news/super-micro-smci-wins-a-new-street-high-price-target-from-northland-securities)
* [3 Penny Stocks to Watch Now, 2/13/25](https://www.tipranks.com/news/3-penny-stocks-to-watch-now-2-13-25)

[tipranks_announcements](https://www.tipranks.com/news/company-announcements/shanghai-bio-heart-approves-strategic-resolutions-during-recent-meetings)
